Research and pipeline 세레스에프앤디의 연구를 소개합니다.

    면역억제제

    *Use of Alteogen-based Technology / **Possession of business rights of Alteogen production goods

    Sirolimus (Expect to industrialization research on 3rd quater of 2019)

    Structures

    Structures Structures Structures

    Mechanism

    • Sirolimus inhibits activation of T cells and B cells by reducing
      their sensitivity to interleukin-2 (IL-2) through mTOR inhibition.

    Producer

    • S. hygroscopicus
    Structures